NO20073732L - Arylpiperazinderivater og anvendelse derav som 5-HT1A-receptorligander - Google Patents
Arylpiperazinderivater og anvendelse derav som 5-HT1A-receptorliganderInfo
- Publication number
- NO20073732L NO20073732L NO20073732A NO20073732A NO20073732L NO 20073732 L NO20073732 L NO 20073732L NO 20073732 A NO20073732 A NO 20073732A NO 20073732 A NO20073732 A NO 20073732A NO 20073732 L NO20073732 L NO 20073732L
- Authority
- NO
- Norway
- Prior art keywords
- receptor ligands
- arylpiperazine derivatives
- ht1a receptor
- ht1a
- derivatives
- Prior art date
Links
- 239000003446 ligand Substances 0.000 title abstract 2
- 102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 title 1
- 101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 title 1
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 208000026723 Urinary tract disease Diseases 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 230000000994 depressogenic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000009424 thromboembolic effect Effects 0.000 abstract 1
- 208000014001 urinary system disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04106998A EP1674103A1 (en) | 2004-12-27 | 2004-12-27 | Arylpiperazine derivatives and use thereof as 5-HT1A receptor ligands |
PCT/EP2005/057175 WO2006069993A1 (en) | 2004-12-27 | 2005-12-27 | Arylpiperazine derivatives and use thereof as 5-ht1a receptor ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20073732L true NO20073732L (no) | 2007-09-18 |
Family
ID=34930175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20073732A NO20073732L (no) | 2004-12-27 | 2007-07-18 | Arylpiperazinderivater og anvendelse derav som 5-HT1A-receptorligander |
Country Status (14)
Country | Link |
---|---|
US (1) | US20090036455A1 (ja) |
EP (2) | EP1674103A1 (ja) |
JP (1) | JP2008525384A (ja) |
KR (1) | KR20070097419A (ja) |
CN (1) | CN101087610A (ja) |
AU (1) | AU2005321228A1 (ja) |
BR (1) | BRPI0519269A2 (ja) |
CA (1) | CA2582663A1 (ja) |
EA (1) | EA200701052A1 (ja) |
IL (1) | IL181955A0 (ja) |
MX (1) | MX2007006842A (ja) |
NO (1) | NO20073732L (ja) |
WO (1) | WO2006069993A1 (ja) |
ZA (1) | ZA200702457B (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2199086B1 (es) | 2002-07-31 | 2005-06-01 | Cepa Schwarz Pharma Sl | Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas. |
WO2023135528A1 (en) | 2022-01-11 | 2023-07-20 | Suven Life Sciences Limited | Heteroalicyclic derivatives and their use in the treatment of cns disorders |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996006846A1 (es) * | 1994-09-01 | 1996-03-07 | Universidad Complutense De Madrid | Nuevos derivados de arilpiperazinas |
-
2004
- 2004-12-27 EP EP04106998A patent/EP1674103A1/en not_active Withdrawn
-
2005
- 2005-12-27 JP JP2007547550A patent/JP2008525384A/ja active Pending
- 2005-12-27 AU AU2005321228A patent/AU2005321228A1/en not_active Abandoned
- 2005-12-27 MX MX2007006842A patent/MX2007006842A/es not_active Application Discontinuation
- 2005-12-27 CA CA002582663A patent/CA2582663A1/en not_active Abandoned
- 2005-12-27 EP EP05825180A patent/EP1830854A1/en not_active Withdrawn
- 2005-12-27 BR BRPI0519269-2A patent/BRPI0519269A2/pt not_active Application Discontinuation
- 2005-12-27 EA EA200701052A patent/EA200701052A1/ru unknown
- 2005-12-27 CN CNA2005800448977A patent/CN101087610A/zh active Pending
- 2005-12-27 US US11/722,786 patent/US20090036455A1/en not_active Abandoned
- 2005-12-27 WO PCT/EP2005/057175 patent/WO2006069993A1/en active Application Filing
- 2005-12-27 KR KR1020077011197A patent/KR20070097419A/ko not_active Application Discontinuation
-
2007
- 2007-03-15 IL IL181955A patent/IL181955A0/en unknown
- 2007-03-26 ZA ZA200702457A patent/ZA200702457B/en unknown
- 2007-07-18 NO NO20073732A patent/NO20073732L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI0519269A2 (pt) | 2009-01-06 |
CN101087610A (zh) | 2007-12-12 |
US20090036455A1 (en) | 2009-02-05 |
WO2006069993A1 (en) | 2006-07-06 |
EP1830854A1 (en) | 2007-09-12 |
MX2007006842A (es) | 2007-08-08 |
JP2008525384A (ja) | 2008-07-17 |
IL181955A0 (en) | 2007-07-04 |
CA2582663A1 (en) | 2006-07-06 |
ZA200702457B (en) | 2008-04-30 |
EA200701052A1 (ru) | 2008-02-28 |
AU2005321228A1 (en) | 2006-07-06 |
EP1674103A1 (en) | 2006-06-28 |
KR20070097419A (ko) | 2007-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20076638L (no) | Nye 8-sulfonylamino-3-aminosubstituerte kroman- eller tetrahydronaftalenderivater som modulerer 5HT6-reseptoren | |
NO20082673L (no) | Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens | |
NO20090755L (no) | Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens | |
NO20063620L (no) | Arylanilinderivater som beta2 adrenergiske receptoragonister | |
BRPI0508724A (pt) | derivados do fenilaminoetanol como agonistas do receptor beta2 | |
NO20064151L (no) | Nye forbindelser | |
MA29088B1 (fr) | Composes d'indazole-carboxamide. | |
WO2005013892A3 (en) | Hydrolytically-resistant boron-containing therapeutics and methods of use | |
NO20065984L (no) | Forbindelser og sammensetninger som PPAR modulatorer | |
NO20083197L (no) | Substituert cinnolin-derivater som GABAA-reseptor modulatorer og metode for deres syntese | |
DK1716152T3 (da) | Kondenserade heterocykliske forbindelser og deres anvendelse som metabotrope receptorantagonister til behandling af gastrointentinde lidelser | |
NO20055219L (no) | Nye forbindelser | |
NO20064156L (no) | Indazolkarboksamidforbindelser som 5-HT4 receptoragonister | |
NO20071660L (no) | Nye pyridinonderivater og deres anvendelse som positive allosteriske modulatorer av MGLUR2-reseptorer | |
ATE423769T1 (de) | Fluor- und sulfonylaminohaltige, 3,6- disubstituierte azabicyclo 3.1.0 hexanderivate als muscarinrezeptorantagonisten | |
ES2282685T3 (es) | Derivados de hidroxietilamina para el tratamiento de la enfermedad de alzheimer. | |
NO20082026L (no) | Deazapuriner som er nyttige som inhibitorer for Janus-kinaser | |
NO20090166L (no) | Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens | |
NO20065983L (no) | Forbindelser og sammensetninger som PPAR modulatorer | |
TW200720260A (en) | Prokineticin 1 receptor antagonists | |
NO20064951L (no) | 1,3,4-oksadiazol-2-oner som PPAR delta-modulatorer og deres anvendelse | |
TW200716566A (en) | Prokineticin 2 receptor antagonists | |
NO20072348L (no) | Thienopyridinone sammensetninger og fremgangsmate for behandling | |
ATE441646T1 (de) | 5-ht4-rezeptoragonistenverbindungen | |
ATE431824T1 (de) | Chinolinon-carboxamid-verbindungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |